Caprion Collaborating with G3 on Biomarkers for Cardiovascular Disease | GenomeWeb

NEW YORK (GenomeWeb News) – Global Genomics Group and Caprion Proteomics said today that they have entered into a collaboration to investigate potential biomarkers and pharmaceutical targets for cardiovascular disease.

Under the agreement, Caprion will identify blood-based protein markers for the ongoing GLOBAL (Genetic Loci and Burden of Atherosclerotic Lesions) study, a multi-center pan-omic study that aims to recruit up to 10,000 patients to characterize disease pathways and biomarkers linked to coronary artery disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.